Advertisement
Screener

TELEFLEX INCORPORATED (TFX) Investing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

TELEFLEX INCORPORATED Investing Cash Flow

TELEFLEX INCORPORATED (TFX) reported Investing Cash Flow of -$826.78 million for the 9-month period ending 2025-09-28, per its 10-Q filed 2025-11-06.

Financial Statements › Cash Flow › Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2025-11-06

  • TELEFLEX INCORPORATED net cash provided by (used in) investing activities for the quarter ending 2025-09-28 was -$767.50M.
  • TELEFLEX INCORPORATED net cash provided by (used in) investing activities for the quarter ending 2025-06-29 was -$30.49M.
  • TELEFLEX INCORPORATED net cash provided by (used in) investing activities for the quarter ending 2025-03-30 was -$28.79M.
  • TELEFLEX INCORPORATED net cash provided by (used in) investing activities for the quarter ending 2024-09-29 was -$21.23M.
  • TELEFLEX INCORPORATED net cash provided by (used in) investing activities for fiscal 2021 was $156.74M.
  • TELEFLEX INCORPORATED net cash provided by (used in) investing activities for fiscal 2020 was -$837.78M.
  • TELEFLEX INCORPORATED net cash provided by (used in) investing activities for fiscal 2019 was -$73.48M.
  • TELEFLEX INCORPORATED net cash provided by (used in) investing activities for fiscal 2018 was -$196.39M.
Period endNet Cash Provided by (Used in) Investing Activities 3 monthNet Cash Provided by (Used in) Investing Activities 6 monthNet Cash Provided by (Used in) Investing Activities 9 monthNet Cash Provided by (Used in) Investing Activities 12 month
2025-09-28-$767.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$797.99M
derived: sum of 2 quarters · filed 2025-11-06
-$826.78M
10-Q · filed 2025-11-06
2025-06-29-$30.49M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31
-$59.28M
10-Q · filed 2025-07-31
2025-03-30-$28.79M
10-Q · filed 2025-05-01
2024-09-29-$21.23M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$51.46M
derived: sum of 2 quarters · filed 2025-11-06
-$76.27M
10-Q · filed 2025-11-06
2024-06-30-$30.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31
-$55.04M
10-Q · filed 2025-07-31
2024-03-31-$24.81M
10-Q · filed 2025-05-01
2023-10-01-$28.47M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31
-$35.80M
derived: sum of 2 quarters · filed 2024-10-31
-$57.70M
10-Q · filed 2024-10-31
2023-07-02-$7.33M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02
-$29.23M
10-Q · filed 2024-08-02
2023-04-02-$21.90M
10-Q · filed 2024-05-03
2022-09-25-$12.64M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03
-$44.39M
derived: sum of 2 quarters · filed 2023-11-03
-$57.21M
10-Q · filed 2023-11-03
-$68.20M
derived: sum of 4 quarters · filed 2023-11-03
2022-06-26-$31.76M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
-$44.57M
10-Q · filed 2023-08-03
-$55.56M
derived: sum of 3 quarters · filed 2023-08-03
$143.92M
derived: sum of 4 quarters · filed 2023-08-03
2022-03-27-$12.82M
10-Q · filed 2023-05-04
-$23.80M
derived: sum of 2 quarters · filed 2023-05-04
$175.68M
derived: sum of 3 quarters · filed 2023-05-04
$164.80M
derived: sum of 4 quarters · filed 2023-05-04
2021-12-31-$10.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$188.49M
derived: sum of 2 quarters · filed 2022-10-27
$177.61M
derived: sum of 3 quarters · filed 2022-10-27
$156.74M
10-K · filed 2022-03-01
2021-09-26$199.48M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27
$188.60M
derived: sum of 2 quarters · filed 2022-10-27
$167.73M
10-Q · filed 2022-10-27
-$351.23M
derived: sum of 4 quarters · filed 2022-10-27
2021-06-27-$10.88M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-28
-$31.76M
10-Q · filed 2022-07-28
-$550.71M
derived: sum of 3 quarters · filed 2022-07-28
-$574.98M
derived: sum of 4 quarters · filed 2022-07-28
2021-03-28-$20.88M
10-Q · filed 2022-04-28
-$539.83M
derived: sum of 2 quarters · filed 2022-04-28
-$564.10M
derived: sum of 3 quarters · filed 2022-04-28
-$574.22M
derived: sum of 4 quarters · filed 2022-04-28
2020-12-31-$518.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
-$543.22M
derived: sum of 2 quarters · filed 2022-03-01
-$553.34M
derived: sum of 3 quarters · filed 2022-03-01
-$837.78M
10-K · filed 2022-03-01
2020-09-27-$24.27M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28
-$34.38M
derived: sum of 2 quarters · filed 2021-10-28
-$318.83M
10-Q · filed 2021-10-28
-$318.71M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-28-$10.12M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29
-$294.56M
10-Q · filed 2021-07-29
-$294.44M
derived: sum of 3 quarters · filed 2022-03-01
2020-03-29-$284.44M
10-Q · filed 2021-04-29
-$284.33M
derived: sum of 2 quarters · filed 2022-03-01
2019-12-31$116.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
-$73.48M
10-K · filed 2022-03-01
2019-09-29-$73.60M
10-Q · filed 2019-10-31
2018-12-31-$118.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
-$196.39M
10-K · filed 2021-02-25
2018-09-30-$78.30M
10-Q · filed 2019-10-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
HAEMONETICS CORP (HAE)United States$4.821B36.52
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
Heartflow, Inc. (HTFL)United States$4.225B
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85
PULSE BIOSCIENCES, INC. (PLSE)United States$3.696B-24.47
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
AtriCure, Inc. (ATRC)United States$3.089B
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55